573 related articles for article (PubMed ID: 21080282)
1. Generating conditional knockout mice.
Friedel RH; Wurst W; Wefers B; Kühn R
Methods Mol Biol; 2011; 693():205-31. PubMed ID: 21080282
[TBL] [Abstract][Full Text] [Related]
2. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases.
Gavériaux-Ruff C; Kieffer BL
Pharmacol Ther; 2007 Mar; 113(3):619-34. PubMed ID: 17289150
[TBL] [Abstract][Full Text] [Related]
3. Construction of engineered murine embryonic stem cells with conditional knockout of FGFR2 depending on Cre-loxP.
Jianmin W; Ruihua S; Lei C; Liangjun Y; Bo C; Jing S; Yuanbing G; Ling Z; Lin C
Biocell; 2006 Aug; 30(2):269-78. PubMed ID: 16972551
[TBL] [Abstract][Full Text] [Related]
4. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
5. A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse.
Schnütgen F; Doerflinger N; Calléja C; Wendling O; Chambon P; Ghyselinck NB
Nat Biotechnol; 2003 May; 21(5):562-5. PubMed ID: 12665802
[TBL] [Abstract][Full Text] [Related]
6. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.
Lantinga-van Leeuwen IS; Leonhard WN; van de Wal A; Breuning MH; Verbeek S; de Heer E; Peters DJ
Genesis; 2006 May; 44(5):225-32. PubMed ID: 16652363
[TBL] [Abstract][Full Text] [Related]
8. Highly B lymphocyte-specific tamoxifen inducible transgene expression of CreER T2 by using the LC-1 locus BAC vector.
Boross P; Breukel C; van Loo PF; van der Kaa J; Claassens JW; Bujard H; Schönig K; Verbeek JS
Genesis; 2009 Nov; 47(11):729-35. PubMed ID: 19621440
[TBL] [Abstract][Full Text] [Related]
9. Establishment of conditional knockout alleles for the gene encoding the regulator of telomere length (RTEL).
Wu X; Sandhu S; Ding H
Genesis; 2007 Dec; 45(12):788-92. PubMed ID: 18064678
[TBL] [Abstract][Full Text] [Related]
10. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
Jäger R; Maurer J; Jacob A; Schorle H
Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
[TBL] [Abstract][Full Text] [Related]
11. Inducible Cre mice.
Feil S; Valtcheva N; Feil R
Methods Mol Biol; 2009; 530():343-63. PubMed ID: 19266339
[TBL] [Abstract][Full Text] [Related]
12. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
[TBL] [Abstract][Full Text] [Related]
13. Inducible gene inactivation in neurons of the adult mouse forebrain.
Erdmann G; Schütz G; Berger S
BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
[TBL] [Abstract][Full Text] [Related]
14. Efficient removal of loxP-flanked DNA sequences in a gene-targeted locus by transient expression of Cre recombinase in fertilized eggs.
Sunaga S; Maki K; Komagata Y; Ikuta K; Miyazaki JI
Mol Reprod Dev; 1997 Feb; 46(2):109-13. PubMed ID: 9021742
[TBL] [Abstract][Full Text] [Related]
15. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
[TBL] [Abstract][Full Text] [Related]
16. EUCOMM--the European conditional mouse mutagenesis program.
Friedel RH; Seisenberger C; Kaloff C; Wurst W
Brief Funct Genomic Proteomic; 2007 Sep; 6(3):180-5. PubMed ID: 17967808
[TBL] [Abstract][Full Text] [Related]
17. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2.
Higashi AY; Ikawa T; Muramatsu M; Economides AN; Niwa A; Okuda T; Murphy AJ; Rojas J; Heike T; Nakahata T; Kawamoto H; Kita T; Yanagita M
J Immunol; 2009 May; 182(9):5633-40. PubMed ID: 19380810
[TBL] [Abstract][Full Text] [Related]
18. Cre recombinase resources for conditional mouse mutagenesis.
Smedley D; Salimova E; Rosenthal N
Methods; 2011 Apr; 53(4):411-6. PubMed ID: 21195764
[TBL] [Abstract][Full Text] [Related]
19. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
Licht AH; Raab S; Hofmann U; Breier G
Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
